J. Frew

发表

The management of children with lymphomas.

H. Lucraft, J. Lewis, J. Frew, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Priorities for the head and neck cancer patient, their companion and members of the multidisciplinary team and decision regret.

V. Paleri, W. Dobrowsky, A. Fry, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Optimising Radium 223 Therapy for Metastatic Castration-Resistant Prostate Cancer -5-year Real-World Outcome: Focusing on Treatment Sequence and Quality of Life.

I. Pedley, R. McMenemin, R. Pearson, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.

J. Staffurth, V. Hinder, E. Hall, 2022, The Lancet. Oncology.

Diffusion-weighted MRI for Early Response Assessment in the Treatment of Bladder Cancer

R. Plummer, R. Maxwell, P. Thelwall, 2018 .

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma

T. Powles, S. Sundar, S. Brock, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Delays in the diagnosis and treatment of muscle invasive bladder cancer: A pilot project mapping the pathway

I. Pedley, R. Heer, R. Pickles, 2015 .

Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherap

R. Maxwell, J. Mott, J. Wilsdon, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Feasibility study of a randomized controlled trial comparing docetaxel chemotherapy and androgen deprivation therapy with sequential prostatic biopsies from patients with advanced non-castration-resistant prostate cancer.

James M. Wilson, P. Rajan, I. Pedley, 2015, Urologic oncology.

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

G. Rodrigues, J. Staffurth, T. Tsakiridis, 2019, The Lancet. Oncology.

A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm.

T. Powles, S. Sundar, S. Brock, 2022, Journal of Clinical Oncology.

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.

D. Berney, R. Huddart, T. Powles, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.

J. Scarisbrick, S. Whittaker, F. Child, 2017, International journal of radiation oncology, biology, physics.

Variability in prostate and seminal vesicle delineations defined on magnetic resonance images, a multi-observer, -center and -sequence study

Tufve Nyholm, Per Bergström, Joakim Jonsson, 2013, Radiation oncology.

Tolerability and efficacy of anti-androgen manipulation versus taxotere and anti-androgen manipulation in patients with hormone-naive, high-risk/metastatic prostate cancer: A phase II, open-labeled, randomized study.

I. Pedley, N. Soomro, H. Leung, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)

D. Dearnaley, V. Khoo, J. Staffurth, 2019, International journal of radiation oncology, biology, physics.

Dupilumab unmasking cutaneous T‐cell lymphoma: report of a fatal case

C. Bacon, S. Weatherhead, W. Osborne, 2021, Clinical and experimental dermatology.

The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway.

N. Richmond, J. Wyatt, H. Mccallum, 2023, Radiography.

Magnetic Resonance-only Workflow: Implementation in a UK Centre.

I. Pedley, N. Richmond, J. Wyatt, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients.

D. Berney, R. Huddart, T. Powles, 2015 .

VortigERN: Variation of radiotherapy target volume definition, dose to organs at risk (OAR), and clinical target volumes using anatomic (CT) versus combined anatomic and molecular imaging (PET-CT): Intensity-modulated radiotherapy delivered using a tomotherapy hi art machine.

R. Maxwell, J. Mott, J. Wilsdon, 2010 .

OC-0289 Comparison of side effects at 2 years in the randomised PACE-B trial (SBRT vs standard radiotherapy)

J. Staffurth, C. Griffin, W. Chu, 2021, Radiotherapy and Oncology.

An update on clinical outcome data for a phase II randomized study comparing androgen deprivation therapy plus docetaxel versus androgen deprivation therapy alone in men with locally advanced/metastatic hormone sensitive prostate cancer.

I. Pedley, R. McMenemin, A. Azzabi, 2017 .

J. Mott, H. Mccallum, S. Chatterjee, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Prostate Ultrahypofractionation – Rising to Challenges Presents Opportunities in the COVID-19 Era

I. Pedley, R. Chandler, R. Pearson, 2020, Clinical Oncology.